Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data-Reference-Cited by-同舟云学术

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data

Published:2021-08 Issue: Volume:Volume 14 Page:4579-4597
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Lee Chung-Shien^ORCID,Milone Matthew,Seetharamu Nagashree^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference132 articles.

1. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management; 2007. Available from: http://familydoctor.org/161.xml. Accessed November 28, 2020.

2. Cancer Statistics, 2021

3. Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

4. Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation

5. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modular and Diverse Synthesis of Acrylamides by Palladium‐Catalyzed Hydroaminocarbonylation of Acetylene;Angewandte Chemie;2024-09-03

2. Modular and Diverse Synthesis of Acrylamides by Palladium‐Catalyzed Hydroaminocarbonylation of Acetylene;Angewandte Chemie International Edition;2024-09-02

3. Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC);Bioorganic & Medicinal Chemistry;2024-07

4. A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancer;2024-03-20

5. Combination of Osimertinib and Olaparib Therapy to Treat Non-Small Cell Lung Cancer and High-Grade Serous Ovarian Carcinoma: A Case Report;Current Oncology;2024-01-19